A nurse is administering magnesium sulfate IV to a client who has severe preeclampsia.

Which of the following assessments should the nurse perform to monitor for magnesium toxicity? Select all that apply.

A nurse is assessing a client with severe pre-eclampsia who is receiving magnesium sulfate infusion.

Which finding should alert the nurse to suspect magnesium toxicity?

A nurse is reviewing the discharge instructions for a client who had severe preeclampsia and delivered her baby at 34 weeks of gestation by cesarean birth.

Which of the following statements by the client indicates an understanding of the teaching?

A nurse is teaching a pregnant client about the risk factors for pre-eclampsia.

Which of the following should the nurse include? (Select all that apply).

A nurse is caring for a client who has a diagnosis of HELLP syndrome.

The nurse should monitor the client for which of the following complications? (Select all that apply.)

A nurse is evaluating the effectiveness of magnesium sulfate therapy for a client who has eclampsia.

Which of the following outcomes indicates that the therapy is successful?

A nurse is teaching a client who is at risk for developing preeclampsia.

Which of the following statements by the client indicates an understanding of the teaching?

A nurse is caring for a client who has severe preeclampsia and is receiving magnesium sulfate via continuous IV infusion.

Which of the following findings should the nurse identify as an indication of magnesium sulfate toxicity?

A nurse is evaluating the effectiveness of magnesium sulfate therapy for a client with eclampsia.

What clinical indicator would suggest that the therapy is successful?

A nurse is caring for a client who has severe pre-eclampsia and is receiving hydralazine IV.

Which of the following adverse effects should the nurse monitor for?

A nurse is evaluating the effectiveness of magnesium sulfate therapy for a client with eclampsia.

Which of the following findings indicates a therapeutic response?